BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37565907)

  • 21. Construction and Validation of Prognosis Nomogram for Metastatic Lung Squamous Cell Carcinoma: A Population-Based Study.
    Liu Y; Sun M; Xiong Y; Gu X; Zhang K; Liu L
    Technol Cancer Res Treat; 2022; 21():15330338221132035. PubMed ID: 36217877
    [No Abstract]   [Full Text] [Related]  

  • 22. Preoperative prediction of central lymph node metastasis in cN0T1/T2 papillary thyroid carcinoma: A nomogram based on clinical and ultrasound characteristics.
    Li J; Sun P; Huang T; Li L; He S; Ai X; Xiao H; Xue G
    Eur J Surg Oncol; 2022 Jun; 48(6):1272-1279. PubMed ID: 35414404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A nomogram for prediction of distant metastasis in children with wilms tumor: A study based on SEER database.
    Huang Y; Zhang W; Song H; Sun N
    J Pediatr Urol; 2020 Aug; 16(4):473.e1-473.e9. PubMed ID: 32600949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment strategies and predicting lymph node metastasis in elderly patients with papillary thyroid microcarcinoma.
    Li W; Tang Y; Li J; Han W; Wang D; Wang Y
    Medicine (Baltimore); 2021 May; 100(18):e25811. PubMed ID: 33950985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultrasound-based Nomogram for Predicting the Pathological Nodal Negativity of Unilateral Clinical N1a Papillary Thyroid Carcinoma in Adolescents and Young Adults.
    Wei Y; Sun P; Chang C; Tong Y
    Acad Radiol; 2023 Sep; 30(9):2000-2009. PubMed ID: 36609031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Novel Nomogram Predicting Distant Metastasis in T1 and T2 Gallbladder Cancer: A SEER-based Study.
    Cai YL; Lin YX; Jiang LS; Ye H; Li FY; Cheng NS
    Int J Med Sci; 2020; 17(12):1704-1712. PubMed ID: 32714073
    [No Abstract]   [Full Text] [Related]  

  • 27. A nomogram model based on the preoperative clinical characteristics of papillary thyroid carcinoma with Hashimoto's thyroiditis to predict central lymph node metastasis.
    Zhao W; He L; Zhu J; Su A
    Clin Endocrinol (Oxf); 2021 Feb; 94(2):310-321. PubMed ID: 32984984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of an Active Surveillance or Surgery Model to Predict Lymph Node Metastasis in cN0 Papillary Thyroid Microcarcinoma.
    Zhang H; Zheng X; Liu J; Gao M; Qian B
    Front Endocrinol (Lausanne); 2022; 13():896121. PubMed ID: 35937812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nomogram for Preoperative Estimation of Cervical Lymph Node Metastasis Risk in Papillary Thyroid Microcarcinoma.
    Sun J; Jiang Q; Wang X; Liu W; Wang X
    Front Endocrinol (Lausanne); 2021; 12():613974. PubMed ID: 33868164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nomograms based on preoperative multimodal ultrasound of papillary thyroid carcinoma for predicting central lymph node metastasis.
    Dai Q; Liu D; Tao Y; Ding C; Li S; Zhao C; Wang Z; Tao Y; Tian J; Leng X
    Eur Radiol; 2022 Jul; 32(7):4596-4608. PubMed ID: 35226156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic Nomogram for Predicting Lateral Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma.
    Zhuo X; Yu J; Chen Z; Lin Z; Huang X; Chen Q; Zhu H; Wan Y
    Otolaryngol Head Neck Surg; 2022 Mar; 166(3):444-453. PubMed ID: 34058905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and validation of a dynamic nomogram based on conventional ultrasound and contrast-enhanced ultrasound for stratifying the risk of central lymph node metastasis in papillary thyroid carcinoma preoperatively.
    Chen Q; Liu Y; Liu J; Su Y; Qian L; Hu X
    Front Endocrinol (Lausanne); 2023; 14():1186381. PubMed ID: 37409231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nomogram Model Based on Iodine Nutrition and Clinical Characteristics of Papillary Thyroid Carcinoma to Predict Lateral Lymph Node Metastasis.
    Wang J; Gao Y; Zong Y; Gao W; Wang X; Sun J; Miao S
    Cancer Control; 2023; 30():10732748231193248. PubMed ID: 37671703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nomogram prediction for the involution of the ablation zone after radiofrequency ablation treatment in patients with low-risk papillary thyroid carcinoma.
    He H; Zhang Y; Song Q; Zhao J; Li W; Li Y; Luo Y
    Int J Hyperthermia; 2021; 38(1):1133-1139. PubMed ID: 34348562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk prediction for central lymph node metastasis in isolated isthmic papillary thyroid carcinoma by nomogram: A retrospective study from 2010 to 2021.
    Zhao Y; Shi W; Dong F; Wang X; Lu C; Liu C
    Front Endocrinol (Lausanne); 2022; 13():1098204. PubMed ID: 36733797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Independent risk factors evaluation for overall survival and cancer-specific survival in thyroid cancer patients with bone metastasis: A study for construction and validation of the predictive nomogram.
    Tong Y; Huang Z; Hu C; Chi C; Lv M; Li P; Zhao C; Song Y
    Medicine (Baltimore); 2020 Sep; 99(36):e21802. PubMed ID: 32899008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A practical nomogram from the SEER database to predict the prognosis of hepatocellular carcinoma in patients with lymph node metastasis.
    Zhang K; Tao C; Wu F; Wu J; Rong W
    Ann Palliat Med; 2021 Apr; 10(4):3847-3863. PubMed ID: 33752423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishment and validation of a nomogram to predict structural incomplete response in papillary thyroid carcinoma patients: a retrospective study.
    Geng C; Tian S; Gao X; Li X; Ru Q; Zhang P
    J Int Med Res; 2023 Jan; 51(1):3000605221149880. PubMed ID: 36688452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A High-Quality Nomogram for Predicting Lung Metastasis in Newly Diagnosed Stage IV Thyroid Cancer: A Population-Based Study.
    Wang W; Liu J; Xu X; Huo L; Wang X; Gu J
    Technol Cancer Res Treat; 2023; 22():15330338231167807. PubMed ID: 37038628
    [No Abstract]   [Full Text] [Related]  

  • 40. Survival nomogram for patients with metastatic siewert type II adenocarcinoma of the esophagogastric junction: a population-based study.
    Chen K; Deng X; Yang Z; Yu D; Zhang X; Zhang J; Xie D; He Z; Cheng D
    Expert Rev Gastroenterol Hepatol; 2020 Aug; 14(8):757-764. PubMed ID: 32552040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.